ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Background: von Willebrand disease (VWD) is the most common inherited bleeding disorder known in humans. Accurate and timely diagnosis presents numerous challenges. Objective: These evidence-based guidelines of the American Society of Hematology (ASH), the International Society on Thrombosis and Haemostasis (ISTH), the National Hemophilia Foundation (NHF), and the World Federation of Hemophilia (WFH) are intended to support patients, clinicians, and other health care professionals in their decisions about VWD diagnosis. Methods: ASH, ISTH, NHF, and WFH established a multidisciplinary guideline panel that included 4 patient representatives and was balanced to minimize potential bias from conflicts of interest. The Outcomes and Implementation Research Unit at the University of Kansas Medical Center (KUMC) supported the guideline-development process, including performing or updating systematic evidence reviews up to 8 January 2020. The panel prioritized clinical questions and outcomes according to their importance for clinicians and patients. The panel used the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach, including GRADE Evidence-to-Decision frameworks, to assess evidence and make recommendations, which were subsequently subject to public comment. Results: The panel agreed on 11 recommendations. Conclusions: Key recommendations of these guidelines include the role of bleeding-assessment tools in the assessment of patients suspected of VWD, diagnostic assays and laboratory cutoffs for type 1 and type 2 VWD, how to approach a type 1 VWD patient with normalized levels over time, and the role of genetic testing vs phenotypic assays for types 2B and 2N. Future critical research priorities are also identified.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305 · cited 1×
“The certainty was categorized into 4 levels: very low (Å◯◯◯), low (ÅÅ◯◯), moderate (ÅÅÅ◯), and high (ÅÅÅÅ).(7,8,29,30,37-39)”
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies
Whiting, P. F., Rutjes, A. W. S., Westwood, M. E., Mallett, S., Deeks, J. J., Reitsma, J. B., Leeflang, M. M. G., Sterne, J. A. C., Bossuyt, P. M. M., & the QUADAS-2 Group* (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-8-201110180-00009 · Cited by 14,199
GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
Guyatt, G., Oxman, A. D., Akl, E. A., Kunz, R., Vist, G., Brozek, J., Norris, S., Falck-Ytter, Y., Glasziou, P., & deBeer, H. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.026 · Cited by 10,681
Clinical Practice Guidelines We Can Trust
Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, Board on Health Care Services, & Institute of Medicine (2011) · National Academies Press eBooks · doi:10.17226/13058 · Cited by 3,081
GRADE guidelines: 2. Framing the question and deciding on important outcomes
Guyatt, G. H., Oxman, A. D., Kunz, R., Atkins, D., Brozek, J., Vist, G., Alderson, P., Glasziou, P., Falck-Ytter, Y., & Schünemann, H. J. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.09.012 · Cited by 1,911 · cited 1×
“6 Although acknowledging considerable variation in the impact on patient outcomes, the panel considered the following outcomes as critical for clinical decision-making across questions: major bleeding, transfusion and treatment, gastrointestinal bleeding, blood loss, symptom severity, minor…”
Alonso-Coello, P., Schünemann, H. J., Moberg, J., Brignardello-Petersen, R., Akl, E. A., Davoli, M., Treweek, S., Mustafa, R. A., Rada, G., Rosenbaum, S., et al. (2016) · BMJ · doi:10.1136/bmj.i2016 · Cited by 1,317
Self-citationAtkins, D., Eccles, M., Flottorp, S., Guyatt, G. H., Henry, D., Hill, S., Liberati, A., O'Connell, D., Oxman, A. D., Phillips, B., et al. (2004) · BMC Health Services Research · doi:10.1186/1472-6963-4-38 · Cited by 1,235
SADLER, J. E., BUDDE, U., EIKENBOOM, J. C. J., FAVALORO, E. J., HILL, F. G. H., HOLMBERG, L., INGERSLEV, J., LEE, C. A., LILLICRAP, D., MANNUCCI, P. M., et al. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.02146.x · Cited by 1,150
Self-citationThe effect of ABO blood group on the diagnosis of von Willebrand disease
Gill, J., Endres-Brooks, J., Bauer, P., Marks, W. J., & Montgomery, R. (1987) · Blood · doi:10.1182/blood.v69.6.1691.1691 · Cited by 957
Guidelines International Network: Toward International Standards for Clinical Practice Guidelines
Qaseem, A., Forland, F., Macbeth, F., Ollenschläger, G., Phillips, S., van der Wees, P., & for the Board of Trustees of the Guidelines International Network* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-7-201204030-00009 · Cited by 902
RODEGHIERO, F., TOSETTO, A., ABSHIRE, T., ARNOLD, D. M., COLLER, B., JAMES, P., NEUNERT, C., & LILLICRAP, D. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03975.x · Cited by 882
Self-citationAlonso-Coello, P., Oxman, A. D., Moberg, J., Brignardello-Petersen, R., Akl, E. A., Davoli, M., Treweek, S., Mustafa, R. A., Vandvik, P. O., Meerpohl, J., et al. (2016) · BMJ · doi:10.1136/bmj.i2089 · Cited by 814
Self-citationSchünemann, H. J., Wiercioch, W., Etxeandia, I., Falavigna, M., Santesso, N., Mustafa, R., Ventresca, M., Brignardello-Petersen, R., Laisaar, K.-T., Kowalski, S., et al. (2014) · Canadian Medical Association Journal · doi:10.1503/cmaj.131237 · Cited by 686
Self-citationSchünemann, H. J., Wiercioch, W., Brozek, J., Etxeandia-Ikobaltzeta, I., Mustafa, R. A., Manja, V., Brignardello-Petersen, R., Neumann, I., Falavigna, M., Alhazzani, W., et al. (2017) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2016.09.009 · Cited by 645
Self-citationImpact, Diagnosis and Treatment of von Willebrand Disease
Sadler, J. E., Berntorp, E., Bochkov, N., Boulyjenkov, V., Ginsburg, D., Meyer, D., Peake, I., Rodeghiero, F., Srivastava, A., & Mannucci, P. M. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613992 · Cited by 501
Schünemann, H. J., Mustafa, R. A., Brozek, J., Steingart, K. R., Leeflang, M., Murad, M. H., Bossuyt, P., Glasziou, P., Jaeschke, R., Lange, S., et al. (2020) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2019.12.020 · Cited by 405
Self-citationGoodeve, A., Eikenboom, J., Castaman, G., Rodeghiero, F., Federici, A. B., Batlle, J., Meyer, D., Mazurier, C., Goudemand, J., Schneppenheim, R., et al. (2007) · Blood · doi:10.1182/blood-2006-05-020784 · Cited by 398
Self-citationSchünemann, H. J., Mustafa, R. A., Brozek, J., Steingart, K. R., Leeflang, M., Murad, M. H., Bossuyt, P., Glasziou, P., Jaeschke, R., Lange, S., et al. (2020) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2019.12.021 · Cited by 387
Self-citationSchünemann, H. J., Mustafa, R., Brozek, J., Santesso, N., Alonso-Coello, P., Guyatt, G., Scholten, R., Langendam, M., Leeflang, M. M., Akl, E. A., et al. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2016.01.032 · Cited by 350
Self-citationSchünemann, H. J., Al-Ansary, L. A., Forland, F., Kersten, S., Komulainen, J., Kopp, I. B., Macbeth, F., Phillips, S. M., Robbins, C., van der Wees, P., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m14-1885 · Cited by 337
The Vexing Problem of Guidelines and Conflict of Interest: A Potential Solution
Guyatt, G., Akl, E. A., Hirsh, J., Kearon, C., Crowther, M., Gutterman, D., Lewis, S. Z., Nathanson, I., Jaeschke, R., & Schünemann, H. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-11-201006010-00254 · Cited by 325
Letters, numbers, symbols and words: how to communicate grades of evidence and recommendations.
Schünemann, H. J., Best, D., Vist, G. E., & Oxman, A. D. (2003) · PubMed Central · Cited by 289
Guideline panels should seldom make good practice statements: guidance from the GRADE Working Group
Guyatt, G. H., Alonso-Coello, P., Schünemann, H. J., Djulbegovic, B., Nothacker, M., Lange, S., Murad, M. H., & Akl, E. A. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2016.07.006 · Cited by 243
Haberichter, S. L., Balistreri, M., Christopherson, P., Morateck, P., Gavazova, S., Bellissimo, D. B., Manco-Johnson, M. J., Gill, J. C., & Montgomery, R. R. (2006) · Blood · doi:10.1182/blood-2006-04-015065 · Cited by 220
Self-citationBowman, M. L., Riddel, J. P., Rand, M. L., Tosetto, A., da Silva, M. C., & James, P. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03499.x · Cited by 184
Self-citationSchünemann, H. J., Mustafa, R. A., Brożek, J., Steingart, K. R., Leeflang, M., Murad, M. H., Bossuyt, P. M., Glasziou, P., Jaeschke, R., Lange, S., et al. (2020) · LSTM Online Archive (Liverpool School of Tropical Medicine) · doi:10.7892/boris.140684 · Cited by 156
Self-citationSchünemann, H. J., Mustafa, R. A., Brozek, J., Santesso, N., Bossuyt, P. M., Steingart, K. R., Leeflang, M., Lange, S., Trenti, T., Langendam, M., et al. (2019) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2019.02.003 · Cited by 148
Self-citationAcquired von Willebrand syndrome: focused for hematologists
Franchini, M., & Mannucci, P. M. (2020) · Haematologica · doi:10.3324/haematol.2020.255117 · Cited by 125
Schünemann, H. J., Osborne, M., Moss, J., Manthous, C., Wagner, G., Sicilian, L., Ohar, J., McDermott, S., Lucas, L., & Jaeschke, R. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200901-0126st · Cited by 115
Development of a screening tool for identifying women with menorrhagia for hemostatic evaluation
Philipp, C. S., Faiz, A. S., Dowling, N. F., Beckman, M. G., Owens, S. L., Ayers, C. A., & Bachmann, G. A. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.08.070 · Cited by 104
Schneppenheim, R., Budde, U., Krey, S., Drewke, E., Bergmann, F., Lechler, E., Oldenburg, J., & Schwaab, R. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650628 · Cited by 86
Akl, E. A., El-Hachem, P., Abou‐Haidar, H., Neumann, I., Schünemann, H. J., & Guyatt, G. H. (2014) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2014.05.006 · Cited by 82
Alexander, P. E., Gionfriddo, M. R., Li, S., Bero, L. A., Stoltzfus, R. J., Neumann, I., Brito, J. P., Djulbegović, B., Montori, V. M., Norris, S. L., et al. (2015) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2015.09.006 · Cited by 63
Collagen Binding Provides a Sensitive Screen for Variant von Willebrand Disease
Flood, V. H., Gill, J. C., Friedman, K. D., Christopherson, P. A., Jacobi, P. M., Hoffmann, R. G., Montgomery, R. R., Haberichter, S. L., & the Zimmerman Program Investigators (2013) · Clinical Chemistry · doi:10.1373/clinchem.2012.199000 · Cited by 63
Self-citationBorràs, N., Batlle, J., Pérez‐Rodríguez, A., Fernández, M. F. L., Rodríguez-Trillo, Á., Lourés, E., Cid, A. R., Bonanad, S., Cabrera, N., Moret, A., et al. (2017) · Haematologica · doi:10.3324/haematol.2017.168765 · Cited by 63
Developments in the diagnostic procedures for von Willebrand disease
de Jong, A., & Eikenboom, J. C. J. (2015) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13243 · Cited by 62
Self-citationCharacterizing polymorphisms and allelic diversity of von Willebrand factor gene in the 1000 Genomes
Wang, Q. Y., Song, J., Gibbs, R. A., Boerwinkle, E., Dong, J., & Yu, F. L. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12093 · Cited by 56
An international survey to inform priorities for new guidelines on von Willebrand disease
Kalot, M. A., Al‐Khatib, M., Connell, N. T., Flood, V. H., Brignardello‐Petersen, R., James, P. D., Mustafa, R. A., & For the VWD working group (2019) · Haemophilia · doi:10.1111/hae.13881 · Cited by 46
Self-citationde Maistre, E., Volot, F. G., Mourey, G., Aho, S., Ternisien, C., Briquel, M., Bertrand, M.-A., Tardy, B., Frotscher, B., Nguyên, P., et al. (2014) · Thrombosis and Haemostasis · doi:10.1160/th14-02-0108 · Cited by 37
Validation of the first commercial ELISA for type 2N von Willebrand’s disease diagnosis
Veyradier, A., Caron, C., Ternisien, C., et al. (2011) · Haemophilia · doi:10.1111/j.1365-2516.2011.02499.x · Cited by 30
Genetic variants of VWF gene in type 2 von Willebrand disease
Freitas, S. D. S., Rezende, S. M., de Oliveira, L. C., et al. (2019) · Haemophilia · doi:10.1111/hae.13714 · Cited by 10
Pérez‐Rodríguez, A., Batlle, J., Corrales, I., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197876 · Cited by 8
Cited by
ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease
Connell, N. T., Flood, V. H., Brignardello-Petersen, R., Abdul-Kadir, R., Arapshian, A., Couper, S., Grow, J. M., Kouides, P., Laffan, M., Lavin, M., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003264 · Cited by 402
Self-citation
Metadata
- Authors
- James, P. D., Connell, N. T., Ameer, B., Di Paola, J., Eikenboom, J., Giraud, N., Haberichter, S., Jacobs-Pratt, V., Konkle, B., McLintock, C., McRae, S., R. Montgomery, R., O’Donnell, J. S., Scappe, N., Sidonio, R., Flood, V. H., Husainat, N., Kalot, M. A., & Mustafa, R. A.
- Venue
- Blood Advances
- Publisher
- American Society of Hematology
- Published
- 2021-01-12
- Volume
- 5
- Issue
- 1
- Pages
- 280-300
- ISSN
- 2473-9529 (ISSN-L)
- 2473-9537
- OpenAlex
- W3121114429
- Cited by
- 586
- References
- 43
- FWCI
- 48.57
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.